Bruehlman Ronald E 4

What Happened

• Ronald E. Bruehlman, a director of GoodRx Holdings, Inc. (GDRX), was granted 73,434 deferred stock units (DSUs) on 2026-06-16. The Form 4 reports the units at $0.00 per unit (award/grant), so no cash purchase was made. Each DSU represents a contingent right to receive one share of Class A common stock in the future.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-17 (appears timely).
• Transaction type/code: A — Award/Grant/Other Acquisition.
• Shares/units granted: 73,434 deferred stock units; price reported: $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote summary: The DSUs vest in full on the earlier of (i) one year after June 16, 2026, or (ii) the 2027 Annual Meeting of Stockholders, subject to continued service. DSUs will settle upon the earliest of Dec 31, 2031; separation from service; change in control; death; or disability, per the company’s Deferred Compensation Plan for Directors.

Context

• Deferred stock units are not immediate share ownership; they are a contingent right to receive shares later (often used for director compensation and deferral of taxes). This is an award rather than an open-market purchase or sale and does not necessarily signal a buy/sell decision by the insider.